Director of Corporate Strategy, Seer

$190-230k

Senior and Expert level

San Francisco Bay Area

Office located in Redwood City, CA

Empowering the scientific community through the power of proteomics

Be an early applicant

Empowering the scientific community through the power of proteomics

101-200 employees

B2BEnterpriseScienceBiotechnology

Be an early applicant

$190-230k

Senior and Expert level

San Francisco Bay Area

Office located in Redwood City, CA

101-200 employees

B2BEnterpriseScienceBiotechnology

Company mission

To decode the secrets of the proteome to improve human health.

Job

Company

Role

Who you are

Bachelor’s degree in Business, Finance, or Biological Sciences
Master’s/MBA preferred
5+ years in strategy, consulting, or finance
Minimum 2+ years of direct experience in Strategy or Management Consulting
Exceptional strategic thinking, quantitative rigor, and the executive presence necessary to drive change in a fast-paced environment

What the job involves

The Director, Corporate Strategy drives quantitative and qualitative analysis for high-priority, cross-functional issues—ranging from M&A evaluation to market entry—and provides actionable recommendations to senior leadership
Strategic Planning: Assess operational performance through market research and data analysis to lead long-term strategic planning and corporate prioritization
Research & Insights: Lead innovative market-based research to identify growth opportunities, synthesizing complex data into high-impact insights for executive decision-making
Executive Communication: Craft compelling narratives, memos, and presentations to influence senior leadership and align internal/external stakeholders
Project Leadership: Manage complex strategy projects across organizational boundaries, overseeing end-to-end deliverables, timelines, and resource allocation
Corporate Development: Monitor global market trends and the M&A landscape to develop deal theses and conduct landscape analyses of potential targets

Our take

Seer offers tools and solutions that provide unbiased, deep, rapid and large-scale proteomics in the field of biotechnology. More specifically, Seer's life sciences and health data platform helps detect life-threatening diseases before symptoms start to show. The company claims to be able to analyze protein composition in a comparable way to sequencing machines ‘reading’ strands of DNA.

Seer has grown rapidly: the company went public in 2020 after being founded in 2017, and enjoys strong financial backing that has helped it launch a varied range of proteomics products.

Seer faces competition from the likes of Nautilus and Illumina, a multibillion giant in the sequencing world, who have a sub-division dedicated to proteomics. However, Seer has featured on the Deloittes Fast500 2023 and won multiple awards for its innovative product, putting it in good stead to grow rapidly.

Steph

Company Specialist at Welcome to the Jungle

Insights

19% employee growth in 12 months

Glassdoor (3.7)

Company

Funding (last 2 of 5 rounds)

Jul 2020

$55m

SERIES D

Dec 2019

$55m

SERIES D

Total funding: $169.5m

Company benefits

Family and Medical Leave Act
Pay Transparency Nondiscrimination Provision
E-Verify Participation Notice
Anti-Discrimination Notice/Right to Work

Company HQ

Redwood Shores, Redwood City, CA

Leadership

Omid Farokhzad

(Chair and CEO)

Extensive experience as Chair, Director and Co-founder across multiple companies and technology platforms. Also a graduate of Harvard Medical School.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job